127 related articles for article (PubMed ID: 37369160)
41. Systemic and intestinal levels of factor XIII-A: the impact of inflammation on expression in macrophage subtypes.
Soendergaard C; Kvist PH; Seidelin JB; Pelzer H; Nielsen OH
J Gastroenterol; 2016 Aug; 51(8):796-807. PubMed ID: 26660730
[TBL] [Abstract][Full Text] [Related]
42. KFL2 participates in the development of ulcerative colitis through inhibiting inflammation via regulating cytokines.
Wang ZL; Wang YD; Wang K; Li JA; Li L
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4941-4948. PubMed ID: 30070340
[TBL] [Abstract][Full Text] [Related]
43. Chemical profile of Xian-He-Cao-Chang-Yan formula and its effects on ulcerative colitis.
Li J; Li M; Ye K; Jiang Q; Wang M; Wen X; Yang J
J Ethnopharmacol; 2021 Mar; 267():113517. PubMed ID: 33164773
[TBL] [Abstract][Full Text] [Related]
44. Evidence for the butyrate metabolism as key pathway improving ulcerative colitis in both pediatric and adult patients.
Zhou Z; Cao J; Liu X; Li M
Bioengineered; 2021 Dec; 12(1):8309-8324. PubMed ID: 34592880
[TBL] [Abstract][Full Text] [Related]
45. Mucosal CXCR4+ IgG plasma cells contribute to the pathogenesis of human ulcerative colitis through FcγR-mediated CD14 macrophage activation.
Uo M; Hisamatsu T; Miyoshi J; Kaito D; Yoneno K; Kitazume MT; Mori M; Sugita A; Koganei K; Matsuoka K; Kanai T; Hibi T
Gut; 2013 Dec; 62(12):1734-44. PubMed ID: 23013725
[TBL] [Abstract][Full Text] [Related]
46. Proteomic characterization of four subtypes of M2 macrophages derived from human THP-1 cells.
Li P; Ma C; Li J; You S; Dang L; Wu J; Hao Z; Li J; Zhi Y; Chen L; Sun S
J Zhejiang Univ Sci B; 2022 May; 23(5):407-422. PubMed ID: 35557041
[TBL] [Abstract][Full Text] [Related]
47. Change of monocytes/macrophages in ulcerative colitis patients with symptoms of anxiety and depression.
Gao X; Duan S; Cao Y; Zhang Y
BMC Gastroenterol; 2023 Mar; 23(1):67. PubMed ID: 36906523
[TBL] [Abstract][Full Text] [Related]
48. Colonic Mucosal Transcriptomic Changes in Patients with Long-Duration Ulcerative Colitis Revealed Colitis-Associated Cancer Pathways.
Low END; Mokhtar NM; Wong Z; Raja Ali RA
J Crohns Colitis; 2019 May; 13(6):755-763. PubMed ID: 30954025
[TBL] [Abstract][Full Text] [Related]
49. Turmeric-derived nanovesicles as novel nanobiologics for targeted therapy of ulcerative colitis.
Gao C; Zhou Y; Chen Z; Li H; Xiao Y; Hao W; Zhu Y; Vong CT; Farag MA; Wang Y; Wang S
Theranostics; 2022; 12(12):5596-5614. PubMed ID: 35910802
[No Abstract] [Full Text] [Related]
50. Preconditioning of bone marrow-derived mesenchymal stem cells highly strengthens their potential to promote IL-6-dependent M2b polarization.
Philipp D; Suhr L; Wahlers T; Choi YH; Paunel-Görgülü A
Stem Cell Res Ther; 2018 Oct; 9(1):286. PubMed ID: 30359316
[TBL] [Abstract][Full Text] [Related]
51. [Bioinformatic analysis of differentially expressed genes and Chinese medicine prediction for ulcerative colitis].
Hu ZR; Zheng WJ; Yan Q; Hu WW; Sun XS
Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(7):1684-1690. PubMed ID: 32489050
[TBL] [Abstract][Full Text] [Related]
52. Confocal laser endomicroscopy: a new gold standard for the assessment of mucosal healing in ulcerative colitis.
Macé V; Ahluwalia A; Coron E; Le Rhun M; Boureille A; Bossard C; Mosnier JF; Matysiak-Budnik T; Tarnawski AS
J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():85-92. PubMed ID: 25827810
[TBL] [Abstract][Full Text] [Related]
53. Heat shock transcription factor 2 predicts mucosal healing and promotes mucosal repair of ulcerative colitis.
Wen Y; Niu J; Zhang F; Wu J; Li M; Sun Y; Wang W; Xia S; Tan Y; Wang K; Miao Y
Scand J Gastroenterol; 2020 Jun; 55(6):677-686. PubMed ID: 32538201
[No Abstract] [Full Text] [Related]
54. Platelet Derived Vesicles Enhance the TGF-beta Signaling Pathway of M1 Macrophage.
Song N; Pan K; Chen L; Jin K
Front Endocrinol (Lausanne); 2022; 13():868893. PubMed ID: 35370988
[TBL] [Abstract][Full Text] [Related]
55. Mucosal synthesis and release of prostaglandin E2 from activated eosinophils and macrophages in ulcerative colitis.
Raab Y; Sundberg C; Hällgren R; Knutson L; Gerdin B
Am J Gastroenterol; 1995 Apr; 90(4):614-20. PubMed ID: 7717321
[TBL] [Abstract][Full Text] [Related]
56. Adipose-derived mesenchymal stem cells may reduce intestinal epithelial damage in ulcerative colitis by communicating with macrophages and blocking inflammatory pathways: an analysis
Zhang N; Chen Y; Huang C; Wei M; Li T; Lv Y; Song Q; Mo S
Aging (Albany NY); 2022 Mar; 14(6):2665-2677. PubMed ID: 35315792
[TBL] [Abstract][Full Text] [Related]
57. Macrophage-based nanotherapeutic strategies in ulcerative colitis.
Zhang J; Zhao Y; Hou T; Zeng H; Kalambhe D; Wang B; Shen X; Huang Y
J Control Release; 2020 Apr; 320():363-380. PubMed ID: 32001299
[TBL] [Abstract][Full Text] [Related]
58. A long noncoding RNA signature for ulcerative colitis identifies IFNG-AS1 as an enhancer of inflammation.
Padua D; Mahurkar-Joshi S; Law IK; Polytarchou C; Vu JP; Pisegna JR; Shih D; Iliopoulos D; Pothoulakis C
Am J Physiol Gastrointest Liver Physiol; 2016 Sep; 311(3):G446-57. PubMed ID: 27492330
[TBL] [Abstract][Full Text] [Related]
59. GPR84 signaling promotes intestinal mucosal inflammation via enhancing NLRP3 inflammasome activation in macrophages.
Zhang Q; Chen LH; Yang H; Fang YC; Wang SW; Wang M; Yuan QT; Wu W; Zhang YM; Liu ZJ; Nan FJ; Xie X
Acta Pharmacol Sin; 2022 Aug; 43(8):2042-2054. PubMed ID: 34912006
[TBL] [Abstract][Full Text] [Related]
60. Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy.
Caprioli F; Bosè F; Rossi RL; Petti L; Viganò C; Ciafardini C; Raeli L; Basilisco G; Ferrero S; Pagani M; Conte D; Altomare G; Monteleone G; Abrignani S; Reali E
Inflamm Bowel Dis; 2013; 19(4):729-39. PubMed ID: 23448791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
